Pharmacoprotective influences on different links of the mechanism underlying 6-hydroxydopamine-induced degeneration of nigro-striatal dopaminergic neurons

By Talanov S.   Oleshko N.   Tkachenko M.   Sagach V.  

Neurophysiology, Vol. 38, Iss. 2, 2006-03 ,pp. : 128-133

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat

By Kirik D.   Rosenblad C.   Bjorklund A.  

Experimental Neurology, Vol. 152, Iss. 2, 1998-08 ,pp. : 259-277

Elsevier

Access to resources Recommend Favorite

Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway

By Deumens R.   Blokland A.   Prickaerts J.  

Experimental Neurology, Vol. 175, Iss. 2, 2002-06 ,pp. : 303-317

Elsevier

Access to resources Recommend Favorite

Cyclosporin A Attenuates the Decrease in Tyrosine Hydroxylase Immunoreactivity in Nigrostriatal Dopaminergic Neurons and in Striatal Dopamine Content in Rats with Intrastriatal Injection of 6-Hydroxydopamine

By Matsuura K.   Makino H.   Ogawa N.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 526-535

Elsevier

Access to resources Recommend Favorite

Mice with a Partial Deficiency of Manganese Superoxide Dismutase Show Increased Vulnerability to the Mitochondrial Toxins Malonate, 3-Nitropropionic Acid, and MPTP

By Andreassen O.A.   Ferrante R.J.   Dedeoglu A.   Albers D.W.   Klivenyi P.   Carlson E.J.   Epstein C.J.   Beal M.F.  

Experimental Neurology, Vol. 167, Iss. 1, 2001-01 ,pp. : 189-195

Elsevier

Access to resources Recommend Favorite